formato europeo per il curriculum vitae

INFORMAZIONI PERSONALI
Nome
Data di nascita
Qualifica
Incarico attuale
Numero telefonico
dell’ufficio
Fax dell’ufficio
E-mail istituzionale
MATTEO PELOSINI
28 LUGLIO 78
MEDICO CHIRUGO, SPECIALISTA IN EMATOLGIA
DIRIGENTE MEDICO, CENTRO AZIENDALE EMATOLOGIA
0586223416, 0586223284, 0586223458
0586223284
[email protected]
TITOLI DI STUDIO E
PROFESSIONALI ED
ESPERIENZE LAVORATIVE
Titolo di studio
Altri titoli di studio e professionali
Esperienze professionali (incarichi
ricoperti
Laurea Specialistica in Medicina e Chirurgia 2003
Specializzazione in Ematologia 2007
Dottore di Ricerca in Microbiologia e Genetica 2012
Medico in formazione c/o U.O. Ematologia Pisa periodo 2004-2007
Visiting physician c/o MD Anderson Cancer Center, Houston, TX, USA 2008
Attività medica c/o U.O. Ematologia Pisa nel campo delle patologie oncoloematologiche
e dei trapianti
Attività di assistenza domiciliare nei pazienti ematologici
Dottorando di ricerca in microbiologia e genetica 2009-2012
Assunzione come dirigente medico ematologo c/ Centro Aziendale Ematologia, Livorno
Capacità linguistiche
• Capacità di lettura
• Capacità di scrittura
• Capacità di espressione orale
• Capacità di uso delle tecnologie
INGLESE
BUONA
BUONA
BUONA
COMPLETA AUTONOMIA NELL'USO DEI SUPPORTI INFERMATICI
Altro (partecipazione a convegni e
seminari, pubblicazioni, collaborazione
a riviste, ecc., ed ogni altra
informazione che il dirigente ritiene di
dover pubblicare)
ARTICOLI
Pelosini, M., Benedetti, E.,Galimberti, S., Caracciolo, F., Petrini,M., Fazzi, R., Andreazzoli, F.,
Papineschi, F., Granulocytic sarcoma and subsequent acute leukemia recurrenee with different
biologic characteristic 5 years after Allogeneic bone marrow transplantation for acute myeloid
leukemia. Bone Marrow Transplantation, , num. 9, vol. 37, pp. 897-898, 2006
Pelosini M, Galimberti S, Benedetti E, Caracciolo F, Fazzi R, Petrini M, Papineschi F. Skin and
stomach graft versus host disease after syngeneic BMT in CML: A case report.
Leuk Res. 2007
Feb 26;
Cervetti G, Carulli G, Galimberti S, Azzara A, Buda G, Orciuolo E, Pelosini M, Petrini M.
Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid
leukemia.
Leuk Res. 2007 Apr 23
Galimberti S, Palumbo GA, Caracciolo F, Benedetti E, Pelosini M, Brizzi S, Ciabatti E, Fazzi R,
Stelitano C, Quintana G, Conte E, Tibullo D, Di Raimondo F, Petrini M The efficacy of rituximab
plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and
FCgammaRIIa polymorphisms. J Chemother. 2007 Jun;19(3):315-21.
Pelosini M, Focosi D, Rita F, Galimberti S, Caracciolo F, Benedetti E, Papineschi F, Petrini M.
Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative
hematological patients and review of literature. Ann Hematol. 2008 May;87(5):405-12. Epub
2007 Dec 7.
Qazilbash MH, Saliba RM, Nieto Y, Parikh G, Pelosini M, Khan FB, Jones RB, Hosing C,
Mendoza F, Weber DM, Wang M, Popat U, Alousi A, Anderlini P, Champlin RE, Giralt S. Arsenic
trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial. Biol
Blood Marrow Transplant. 2008 Dec;14(12):1401-7.
Focosi D, Pelosini M, Palla P, Galimberti S, Caracciolo F, Benedetti E, Papineschi F, Petrini M.
Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on
hemodialysis undergoing autologous stem cell transplantation: Clinical response after plasma
exchange. Transpl Immunol. 2009 Jun 16.
Pelosini M., Baronti F., Petrini M. “Application of a compiter science Analysis to a Non Hodgkin
Lymphomas patients’dataset”. Computational intelligence and bioengineering. IOS Press. 2009,
Vol 196 edited by Masulli F: Micheli A. Sperduti A.
Orciuolo E, Buda G, Pelosini M, Petrini M. Fludarabine, Bortezomib, Myocet and rituximab
chemotherapy in relapsed and refractory mantle cell lymphoma. Br J Haematol. 2010
Mar;148(5):810-2. Epub 2009 Nov 16.
Efebera YA, Qureshi SR, Cole SM, Saliba R, Pelosini M, Patel RM, Koca E, Mendoza FL, Wang
M, Shah J, Alousi A, Hosing C, Popat U, Kebriaei P, Anderlini P, Khouri IF, Champlin R, Giralt S,
Qazilbash MH. Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed
multiple myeloma. Biol Blood Marrow Transplant. 2010 Aug;16(8):1122-9. Epub 2010 Feb 21.
Buda G, Carulli G, Orciuolo E, Cannizzo E, Pelosini M, Galimberti S, Petrini M. CD23 expression
in plasma cell leukaemia. Br J Haematol. 2010 Sep;150(6):724-5.
Tuccori M, Focosi D, Blandizzi C, Pelosini M, Montagnani S, Maggi F, Pistello M, Antonioli L,
Fornai M, Pepe P, Rossi G, Petrini M. Inclusion of rituximab in treatment protocols for nonHodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy. Oncologist.
2010;15(11):1214-9.
Galimberti S, Nagy B, Ciancia E, Caracciolo F, Benedetti E, Pelosini M, Focosi D, Petrini M.
Outcome of patients with mantle cell lymphoma is not influenced by vascular endothelial growth
factor polymorphisms.Leuk Lymphoma. 2011 Jan;52(1):142-4. Epub 2010 Nov 11. No abstract
available.
Buda G, Orciuolo E, Galimberti S, Pelosini M, Petrini M. Pegylated liposomal doxorubicin in
combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple
myeloma pretreated patients. Ann Hematol. 2011 Sep;90(9):1115-6.
Alatrash G, de Lima M, Hamerschlak N, Pelosini M, Wang X, Xiao L, Kerbauy F, Chiattone A,
Rondon G, Qazilbash MH, Giralt SA, de Padua Silva L, Hosing C, Kebriaei P, Zhang W, Nieto Y,
Saliba RM, Champlin RE, Andersson BSMyeloablative reduced-toxicity i.v. busulfan-fludarabine
and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or
myelodysplastic syndrome in the sixth through eighth decades of life.. Biol Blood Marrow
Transplant. 2011 Oct;17(10):1490-6. Epub 2011 Feb 18.
Alatrash G, Pelosini M, Saliba RM, Koca E, Rondon G, Andersson BS, Chiattone A, Zhang W,
Giralt SA, Cernosek AM, Kebriaei P, Alousi AM, Popat UR, Hosing C, Khouri IF, Champlin RE,
de Lima MJ. Platelet recovery before allogeneic stem cell transplantation predicts
posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic
syndrome. Biol Blood Marrow Transplant. 2011 Dec;17(12):1841-5. Epub 2011 May 27.
ABSTRACT
E. Benedetti, F. Papineschi, F. Caracciolo, S. Galimberti, G. Cervetti, G. Castiglioni, S. Mechelli,
P. Scatena, M. Pelosini, M. Petrini, In vivo purging with hyper-CVAD plus rituximab in newly
diagnosed mantle cell lymphoma, Bone Marrow Transplantation, num. 33, SupplI, pp. 912-912,
2004
Benedetti, E., Caracciolo, F., Papineschi, F., Pelosini, M., Andreazzoli, D., Azzarà, A, Carulli,
G.,Petrini, M., Gentuzimab omogozacin plus Flang in refractory/relapsed acute myeloid
leukemias patients and pre-allogeneic stem cell transplant., Bone Marrow Transplantation, num.
Supl.n°2,35, pp. 225-225, 2005
Benedetti, E., Caracciolo,F., Papineschi, F., Galimberti, S., Pelosini, M., Castiglioni,CM.,
Mechelli S., Scatena, Petrini,M., Hyper-CVAD and Rituximab as in vivo purging followed by
autologous stem cell transplant and rituximab maintenance in newly diagnosed mantle cell
lymphoma, Haematologica, num. Suppl.3, 90, pp. 420-420, 2005
Muzaffar H. Qazilbash, Rima M. Saliba, Matteo Pelosini, Chitra M Hosing, Floralyn L Mendoza,
Eric Han, Michael Wang, Donna M. Weber, Amin M. Alousi, Paolo Anderlini, Partow Kebriaei,
Issa F. Khouri, Uday R Popat, Marcos De Lima, Robert Z. Orlowski, Richard E. Champlin, and
Sergio A. Giralt A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and
Arsenic Trioxide with or without Bortezomib in Multiple Myeloma Blood (ASH Annual Meeting
Abstracts), Nov 2008; 112: 3320.
Suzanne M. Cole, Rima Saliba, Matteo Pelosini, Floralyn L Mendoza, Donna Weber, Michael
Wang, Sheeba Thomas, Robert Z. Orlowski, Jatin Shah, Amin Alousi, Chitra Hosing, Uday
Popat, Partow Kebriaei, Paolo Anderlini, Issa F. Khouri, Richard Champlin, Sergio Giralt, and
Muzaffar H. Qazilbash. Reduced-Intensity Regimens for Allogeneic Stem Cell Transplantation
Improve the Outcome in Advanced Multiple Myeloma Blood (ASH Annual Meeting Abstracts),
Nov 2008; 112: 3298
Gheath Alatrash, Matteo Pelosini, Rima M Saliba, Gabriela Rondon, Weiqing Zhang, Sergio
Giralt, Partow Kebriaei, Amin Alousi, Issa F Khouri, Richard E Champlin, and Marcos De Lima
Platelet Recovery Prior to Stem Cell Transplantation Predicts for Post- Transplant Outcomes in
Patients with AML Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3000.
Gheath Alatrash, Borje S. Andersson, Matteo Pelosini, Gabrila Rondon, Muzaffar H. Qazilbash,
Sergio Giralt, Leandro de Padua Silva, Chitra Hosing, Partow Kebriaei, Weiqing Zhang, Rima
Saliba, Richard E. Champlin, and Marcos De Lima Myeloablative, Reduced Toxicity IV
Busulfan/Fludarabine (BuFlu) and Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for
Patients in the 6th and 7th Decades of Life with AML or MDS Blood (ASH Annual Meeting
Abstracts), Nov 2008; 112: 2999.
M. Pelosini, F. Mendoza, C. Hosing, U.R. Popat, P. Anderlini, A.M. Alousi, P. Kebriaei, D.M.
Weber, M. Wang, R.E. Champlin, S.A. Giralt, M.H. Qazilbash. Improved Outcome for Allogeneic
Transplantation Performed After January 2000 Biology of Blood and Marrow
Transplantation.February 2009 (Vol. 15, Issue 2, Pages 68-69)
G. Alatrash, M. Pelosini, R. Saliba, G. Rondon, W. Zhang, S. Giralt, P. Kebriaei,
Alousi, I. Khouri, R. Champlin, M. de Lima Post-Hematopoietic Stem Cell
Transplantation (HSCT) Outcomes in Patients With AML Transplanted Prior to
Achieving Platelet Recovery. Biology of Blood and Marrow Transplantation.
February 2009 (Vol. 15, Issue 2, Page 58)
G. Alatrash, B. Andersson, M. Pelosini, G. Rondon, M. Qazilbash, S. Giralt, L. de
Padua Silva, C. Hosing, P. Kebriaei, W. Zhang, R. Saliba, R. Champlin, M. de
Lima. Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th
and 7th Decades of Life with AML or MDS Using Myeloablative, Reduced Toxicity
IV Busulfan/Fludarabine (BuFlu) Conditioning Regimen. Biology of Blood and
Marrow Transplantation. February 2009 (Vol. 15, Issue 2, Page 106)
Pelosini M. Baronti F. Galimberti S. Caracciolo F., Benedetti E., Papineschi F.,
Starita A., Petrini M. “Autologous stem cell transplantation improve outcome in NoHodgkin Lymphoma: results of a computer science analysis”. Bone marrow
transplantation, Vol 43, supplement 1, March 2009
Benedetti E. Simonetti F. Caracciolo F. Papineschi F, Orsitto E., Tonerini M, Bruno
B., Pelosini M., Focosi D., Petrini M. Neutropenic enterocolitis: usefulness of
ulstrasoind sonography. Single centre experience” Bone marrow transplantation,
Vol 43, supplement 1, March 2009
Benedetti E.. Caracciolo F. Papineschi F, Bruno B., McDonald G.B., Pelosini M.,
Focosi D., Ricchiuti A., Ceccarelli L., Petrini M. “Contrast enhanced ulstrasound
sonography in intestinal acute graft versus host disease “.Bone marrow
transplantation, Vol 43, supplement 1, March 2009